ADVA
13.5.2020 09:02:19 CEST | Business Wire | Press release
ADVA (FSE: ADV) and 6WIND today announced that German telecommunication carrier WiTCOM is using ADVA’s Ensemble Connector and 6WIND’s Turbo IPsec vRouter as key components of its new edge cloud platform. The open multi-vendor solution enables WiTCOM to power its smart city initiative with network functions virtualization (NFV) and universal customer premises equipment (uCPE). Built on best-of-breed technology from five leading suppliers, the solution supports the rapid and efficient rollout of IoT, video and next-generation services across WiTCOM’s IPv6 network and enables easy scalability for global deployments. Other partners in the project are Advantech, dacoso and Dell Technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200513005054/en/
“We took an innovative approach for an open multi-vendor solution to power our smart city initiative working with 6WIND, ADVA, Advantech, Dell Technologies and dacoso,” said Volker Bodenbach, head of technology and operations, WiTCOM. “Together we designed a secure open platform that powers edge cloud for IoT, video and next-generation services across our IPv6 network that can further be deployed worldwide across many verticals.”
WiTCOM’s new multi-vendor platform is composed of technologies optimized for edge cloud architecture. The uCPE approach brings dramatically increased efficiency and scale to the ICT service provider’s business. It also ensures that its customers benefit from ultimate choice and flexibility. Now, WiTCOM can streamline multiple virtual network functions (VNFs) on a single installation deployed close to the end customer, helping cities to digitalize their infrastructure and take advantage of the latest innovation in areas such as traffic control, surveillance and IoT.
“Our Ensemble Connector is the ideal solution for hosting and managing demanding uCPE applications. It’s now giving WiTCOM the power of the cloud along with several other benefits, such as zero-touch provisioning and platform security. It also provides access to the Ensemble Harmony ecosystem, which includes a wide variety of onboarded commercial VNFs,” commented James Buchanan, general manager, Edge Cloud, ADVA. “With its new uCPE network, WiTCOM can respond in an instant to customer demands and empower municipal networks to test out offerings and ideas. It will help accelerate the fourth industrial revolution and be a key tool in transforming cities into safer, less wasteful and more pleasant places to live.”
“6WIND’s vRouters provide the high-performance virtual routing foundation required for secure, scalable uCPE solutions,” said Eric Carmès, founder and CEO, 6WIND. “We are proud to work with WiTCOM alongside our partners ADVA, Advantech, dacoso and Dell Technologies to create an industry-leading smart city initiative for IoT, video and additional services.”
“Our task was to combine the components for this managed edge cloud solution into a finely tuned overall solution,” explained Karsten Geise, head of business and development, dacoso. “IoT via IPv6 public networks will be of great interest to many companies in the future if it meets such high security and automation requirements.”
“WiTCOM’s smart city blueprint extends the cloud infrastructure to the IoT edge, building a solid and open foundation to run innovative mobility and security services,” said James Yang, VP, Cloud-IoT Group, Advantech. “Our white box uCPE solutions help service providers like WiTCOM enable this intelligent edge with optimized platforms that provide ample computing power and rich connectivity while meeting edge environmental and mechanical constraints.”
Further information is available in this case study: https://adva.li/witcom-case-study .
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at: www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200513005054/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom